Circulating Activin A predicts survival in cancer patients
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background: Several experimental evidences pinpoint the possible role of Activin A (ActA) as a driver of cancer cachexia. Supporting this hypothesis, we showed recently that human cancer cachexia is associated with high ActA levels. Moreover, ActA levels were correlated with body weight loss and skeletal muscle density, two prognostic factors in cancer patients. Our goal was therefore to investigate the value of ActA to predict survival in cancer patients. Methods: Patients with colorectal or lung cancer were prospectively enrolled at the time of diagnosis or relapse between January 2012 and March 2014. At baseline, patients had clinical, nutritional, and functional assessment. Body composition and skeletal muscle density were measured by CT scan, and plasma ActA concentrations were determined. Overall survival (OS) was analysed since inclusion to 24 months later. Results: Survival data were available for 149 patients out of 152. Patients with high ActA (≥408 pg/mL) had lower OS than those with low levels, regardless the type of cancer (OS in colorectal cancer, 50% vs. 79%, P < 0.05; and in lung cancer, 27% vs. 67%, P = 0.001). The multivariable analysis confirmed the prognostic value of ActA independently of tumour stage or inflammatory markers, particularly in lung cancer. Low muscularity was also an independent prognostic factor. Conclusions: Our study demonstrates that high ActA level is an independent prognosis factor of survival in cancer patients. More than a basic marker of the severity of the neoplastic disease or of the inflammatory process, ActA seems to influence survival by contributing to the development of cachexia and loss of skeletal muscle mass.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238
Mourtzakis, M., Prado, C. M. M., Lieffers, J. R., Reiman, T., McCargar, L. J., & Baracos, V. E. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-075 · Cited by 2,224 · cited 1×
“Cross-sectional area for muscle and adipose tissues was normalized for stature and expressed as muscle and fat indexes (cm(2)/m(2)).(2,23) All CT-scan images were analysed by a single trained observer, who was blinded to patient’s status.”
MethodMuscle wasting in disease: molecular mechanisms and promising therapies
Cohen, S., Nathan, J. A., & Goldberg, A. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4467 · Cited by 1,089
Goodpaster, B. H., Kelley, D. E., Thaete, F. L., He, J., & Ross, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.1.104 · Cited by 947
Measurement of skeletal muscle radiation attenuation and basis of its biological variation
Aubrey, J., Esfandiari, N., Baracos, V. E., Buteau, F. A., Frenette, J., Putman, C. T., & Mazurak, V. C. (2014) · Acta Physiologica · doi:10.1111/apha.12224 · Cited by 720 · cited 2×
“Cross-sectional area for muscle and adipose tissues was normalized for stature and expressed as muscle and fat indexes (cm(2)/m(2)).(2,23) All CT-scan images were analysed by a single trained observer, who was blinded to patient’s status.”
BackgroundMethodGonzalez-Cadavid, N. F., Taylor, W. E., Yarasheski, K., Sinha-Hikim, I., Ma, K., Ezzat, S., Shen, R., Lalani, R., Asa, S., Mamita, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14938 · Cited by 571
Gilson, H., Schakman, O., Kalista, S., Lause, P., Tsuchida, K., & Thissen, J.-P. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00193.2009 · Cited by 248
Self-citationSjøblom, B., Grønberg, B. H., Wentzel-Larsen, T., Baracos, V. E., Hjermstad, M. J., Aass, N., Bremnes, R. M., Fløtten, Ø., Bye, A., & Jordhøy, M. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.03.010 · Cited by 143
de Kretser, D. M., Bensley, J. G., Pettilä, V., Linko, R., Hedger, M. P., Hayward, S., Allan, C. A., McLachlan, R. I., Ludlow, H., & Phillips, D. J. (2013) · Critical Care · doi:10.1186/cc13093 · Cited by 39
Research works printed but not linked: 39
- 10.1016/j.cmet.2012.06.011 · DOI · Paper page
- 10.1200/JCO.2012.45.2722 · DOI · Paper page
- 10.1016/j.semcdb.2015.09.001 · DOI · Paper page
- 10.1677/JOE-08-0549 · DOI · Paper page
- 10.1016/j.cell.2010.07.011 · DOI · Paper page
- 10.1096/fj.13-245894 · DOI · Paper page
- 10.2174/187152210793663810 · DOI · Paper page
- 10.1002/ijc.29620 · DOI
- 10.1210/jc.81.6.2125 · DOI · Paper page
- 10.1016/j.cytogfr.2013.03.003 · DOI
- 10.1210/jc.2014-4318 · DOI · Paper page
- 10.1093/annonc/mds068 · DOI
- 10.1016/j.canlet.2014.10.037 · DOI
- 10.18632/oncotarget.7796 · DOI · Paper page
- 10.1016/S1470-2045(10)70218-7 · DOI · Paper page
- 10.1245/s10434-010-0985-4 · DOI · Paper page
- 10.1093/ajcn/82.5.1074 · DOI · Paper page
- 10.1093/annonc/mdn537 · DOI · Paper page
- 10.1016/S0167-9473(98)00096-6 · DOI · Paper page
- MandrekarJN MandrekarSJ ChaSS.Cutpoint determination methods in survival analysis using SAS®. SAS® users group international proceedings 282003.
- 10.3390/cancers7010070 · DOI · Paper page
- 10.3892/ol.2015.3248 · doi:10.3892/ol.2015.3248
- 10.1002/hed.23627 · doi:10.1002/hed.23627
- 10.1593/neo.81582 · DOI · Paper page
- Wu S, 2015, Activin A as a novel biomarker for colorectal adenocarcinoma in humans, Eur Rev Med Pharmacol Sci, 19, 4371
- 10.1136/gut.49.3.409 · DOI · Paper page
- 10.1038/icb.2011.12 · DOI
- 10.1073/pnas.0705971104 · DOI · Paper page
- 10.1530/eje.0.1480559 · DOI · Paper page
- 10.1016/j.tem.2012.10.006 · DOI · Paper page
- 10.1016/j.clnu.2011.07.010 · DOI
- 10.1007/s00520-013-1878-4 · DOI
- Yarasheski KE, 2002, Serum myostatin‐immunoreactive protein is increased in 60–92 year old women and men with muscle wasting, J Nutr Health Aging, 6, 343
- 10.1152/ajpheart.00200.2011 · DOI · Paper page
- 10.1016/j.mce.2008.12.019 · DOI
- 10.1093/gerona/glr025 · DOI · Paper page
- 10.1530/EJE-12-0512 · DOI
- 10.1371/journal.pone.0080454 · DOI
- 10.1002/jcsm.12089 · DOI · Paper page
Cited by
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
Justice, J. N., Nambiar, A. M., Tchkonia, T., LeBrasseur, N. K., Pascual, R., Hashmi, S. K., Prata, L., Masternak, M. M., Kritchevsky, S. B., Musi, N., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.052 · Cited by 1,261
Stefanakis, K., Kokkorakis, M., & Mantzoros, C. S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156057 · Cited by 142
Skeletal muscle wasting in chronic heart failure
Suzuki, T., Palus, S., & Springer, J. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12387 · Cited by 134
Nachit, M., Kwanten, W. J., Thissen, J.-P., Op De Beeck, B., Van Gaal, L., Vonghia, L., Verrijken, A., Driessen, A., Horsmans, Y., Francque, S., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.02.037 · Cited by 114
Self-citationMyostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs
Rodgers, B. D., & Ward, C. W. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab030 · Cited by 111
Metadata
- Authors
- Loumaye, A., de Barsy, M., Nachit, M., Lause, P., van Maanen, A., Trefois, P., Gruson, D., & Thissen, J.
- Venue
- Journal of Cachexia, Sarcopenia and Muscle
- Publisher
- Wiley
- Published
- 2017-07-15
- Volume
- 8
- Issue
- 5
- Pages
- 768-777
- ISSN
- 2190-5991 (ISSN-L)
- 2190-6009
- OpenAlex
- W2735619199
- Cited by
- 79
- References
- 9
- FWCI
- 5.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.